| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.69M | - | |
| VP | 141.5K | $11.21M | - | |
| Other | 87.3K | $6.91M | - | |
| VP | 73.6K | $5.82M | -15,000 | |
| CFO | 70.1K | $5.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | Blum Robert I51 | President &CEO | Sale+OE | 11,500 | $59.49 | $684,135.00 | -2.8% | -13.1% | -39.9% | |
| Jul 29, 2024 | Parshall B Lynne74 | Director | Sale+OE | 5,000 | $59.84 | $299,200.00 | -19.5% | -11.6% | -39.2% | |
| Jul 23, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $57.02 | $416,246.00 | -2.8% | -6.2% | -33.9% | |
| Jul 15, 2024 | Parshall B Lynne74 | Director | Sale+OE | 5,000 | $55.82 | $279,100.00 | -19.5% | -5.0% | -33.8% | |
| Jul 10, 2024 | Blum Robert I51 | President &CEO | Sale+OE | 11,500 | $54.29 | $624,335.00 | -2.8% | -1.1% | -33.4% | |
| Jul 9, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $55.90 | $408,103.00 | -2.7% | +1.1% | -33.2% | |
| Jul 5, 2024 | Harrington Robert Arthur51 | Director | Sell | 253 | $54.61 | $13,816.33 | -1.6% | +0.4% | -39.9% | |
| Jul 1, 2024 | Blum Robert I51 | President &CEO | Sell | 11,500 | $54.05 | $621,575.00 | -2.8% | -3.5% | -38.5% | |
| Jul 1, 2024 | Parshall B Lynne74 | Director | Sale+OE | 5,000 | $54.22 | $271,100.00 | -19.5% | -3.5% | -38.5% | |
| Jun 25, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $53.72 | $392,143.00 | -2.7% | -1.5% | -37.4% |